In November 1996, Glaxo Wellcome announced the initiation of a controlled donation program for Malarone, a highly effective new anti-malarial, in partnership with The Task Force for Child Survival and Development. The purpose of the Malarone Donation Program (MDP) is to help combat the problem of drug resistant malaria in endemic countries where cost often limits access to new medicines.
East Africa was selected as the initial focus for Program activity. In collaboration with national authorities, pilot drug donation programs are underway in two sites in Uganda and one in Kenya.
For information, please contact Kim Korporc at: KKoporc@taskforce.org